Nasdaq auph.

Dec 1, 2023 · AUPH Stock Overview. Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States. About the company. AUPH fundamental analysis. Jan 12, 2023 · In trading on Thursday, shares of Aurinia Pharmaceuticals Inc (Symbol: AUPH) crossed above their 200 day moving average of $8.57, changing hands as high as $8.92 per share. Aurinia Pharmaceuticals ... Average Sales Growth Over the Past 5 Years: 873%. Chinese EV company Li Auto Inc. (NASDAQ:LI) ranks 10th in our list of the best stocks with exponential growth to buy according to hedge funds. Li ...Rhumbline Advisers raised its position in shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) by 3.2% in the 2nd quarter, according to the company in its most recent ...Agios Pharmaceuticals (NASDAQ:AGIO) and Aurinia Pharmaceuticals (NASDAQ:AUPH) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, profitability, earnings, community ranking, dividends, valuation, media sentiment, analyst recommendations and institutional ...

Aurinia Pharmaceuticals ( NASDAQ: AUPH) traded ~5% higher pre-market Thursday after the Canadian biotech increased its full-year guidance and posted better-than-expected financials for Q2 2023 ...

Anyone who held Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) over the last year knows what a loser feels like. The share price has slid 66% in that time. The share price has slid 66% in that time.

Nasdaq Insider Activity page provides trading information of corporate insiders (officers, directors and any beneficial owners of more than 10% of a class of the company’s equity securities). An ...See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. AUPH's current price target is …NEW YORK, April 27, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that...Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q3 2023 Earnings Call Transcript November 2, 2023 Aurinia Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.09, expectations were $-0.17.

In trading on Monday, shares of Aurinia Pharmaceuticals Inc (Symbol: AUPH) entered into oversold territory, hitting an RSI reading of 28.7, after changing hands as low as $8.86 per share. By ...

AUPH Earnings Date and Information. Aurinia Pharmaceuticals last released its quarterly earnings results on November 2nd, 2023. The biotechnology company …

This page of Aurinia Pharmaceuticals (AUPH) displays a brief signal update and a market outlook, as well as a candlestick chart showing the last detected ...Mar 9, 2023 · 9.24. +0.64. +7.44%. Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2022 Earnings Call Transcript February 28, 2023 Operator: Greetings, and welcome to the Aurinia Pharmaceuticals Fourth Quarter ... AUPH Stock Overview. Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States. About the company. AUPH fundamental analysis.The OCUL stock price is -140.48% off its 52-week high price of $7.96 and 39.58% above the 52-week low of $2.00. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.72 million shares traded. The 3-month trading volume is 808.59K shares. The consensus among analysts is that Ocular Therapeutix Inc (OCUL ...Cramer said Aurinia Pharmaceuticals Inc. AUPH is a Canadian company that "I don’t really have a lot of confidence in, and I’m not recommending any companies that are losing money hand over ...The average twelve-month price prediction for Aurinia Pharmaceuticals is $14.00 with a high price target of $15.00 and a low price target of $13.00. Learn more on AUPH's analyst rating history. Do Wall Street analysts like Aurinia Pharmaceuticals more than its competitors?NASDAQ:AUPH. Press Releases. May 17, 2023. Aurinia Announces 2023 Annual General Meeting Results May 09, 2023. Aurinia Pharmaceuticals Announces Kidney Biopsies Sub-study Data from the LUPKYNIS ...

Nov 30, 2023 · See the latest Aurinia Pharmaceuticals Inc stock price (AUPH:XNAS), related news, valuation, dividends and more to help you make your investing decisions. That number works out to 54.2% of BC's average daily trading volume over the past month, of 579,215 shares. Especially high volume was seen for the $75 strike put option expiring September 15 ...If you’re familiar with investing, then you’ve probably heard of major stock exchanges like the New York Stock Exchange or the NASDAQ. Stock exchanges are sort of like a mixture between an auction house and a marketplace where investors can...EDMONTON, Alberta--(BUSINESS WIRE)-- Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company), a biopharmaceutical company committed to delivering therapeutics that change the ...AUPH Latest After Hours Trades. Select time range to see more trades: Last 100 Trades. After Hours Time (ET) After Hours Price. After Hours Share Volume. 19:59:23. $9.37. 100.

Dec 4, 2023 · December 4, 2023. Company. Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) has a beta value of 1.39 and has seen 0.72 million shares traded in the recent trading session. The company, currently valued at $1.27B, closed the recent trade at $8.82 per share which meant it lost -$0.24 on the day or -2.60% during that session. Avid Bioservices Inc (NASDAQ:CDMO) has a beta value of 1.52 and has seen 0.52 million shares traded in the recent trading session. The company, currently valued at $305.42M, closed the recent trade at $4.84 per share which meant it lost -$0.15 on the day or -3.11% during that session. ... (NASDAQ:AUPH) has a beta value of 1.39 and has …

About Latest Pre-Market Trades. Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day.The fact that multiple Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) insiders offloaded a considerable amount of shares over the past year could have raised some eyebrows amongst investors. When ...It has been quite some time since we last took a look at Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH). This small biopharma has been somewhat of a roller coaster ride for its shareholders in recent ...View Aurinia Pharmaceuticals Inc AUPH investment & stock information. Get the latest Aurinia Pharmaceuticals Inc AUPH detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Fintel reports that on September 22, 2023, HC Wainwright & Co. reiterated coverage of Aurinia Pharmaceuticals (NASDAQ:AUPH) with a Buy recommendation. Analyst Price Forecast Suggests 72.67% Upside ...Track Aurinia Pharmaceuticals Inc (AUPH) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsGainers Astra Space, Inc. (NASDAQ: ASTR) rose 39.6% to $13.30 in pre-market trading after declining around 3% on Friday. Astra Space recently reported a Q3 loss of $0.06 per share.

Nov 24, 2023 · Aurinia Pharmaceuticals Inc (NASDAQ:AUPH)’s traded shares stood at 0.69 million during the latest session, with the company’s beta value hitting 1.28. At the last check today, the stock’s price was $9.28, to imply an increase of 2.66% or $0.24 in intraday trading.

Jul 27, 2022 · In trading on Wednesday, shares of Aurinia Pharmaceuticals Inc (Symbol: AUPH) entered into oversold territory, hitting an RSI reading of 28.7, after changing hands as low as $7.70 per share. By ...

AUPH Stock 12 Months Forecast. Based on 6 Wall Street analysts offering 12 month price targets for Aurinia Pharmaceuticals in the last 3 months. The average price target is $14.20 with a high forecast of $15.00 and a low forecast of $13.00. The average price target represents a 71.29% change from the last price of $8.29.Aurinia Pharmaceuticals Inc Ordinary Shares (AUPH) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Aurinia AUPH announced that it has acquired two new pipeline candidates, which will target rare autoimmune and kidney-related diseases. Both the candidates, renamed as AUR200 and AUR300 following ...Aurinia Pharmaceuticals (NASDAQ:AUPH) is a biopharmaceutical firm delivering therapies for autoimmune, kidney, and rare diseases with unmet medical …Feb 28, 2022 · What happened. Shares of the autoimmune disease specialist Aurinia Pharmaceuticals (NASDAQ: AUPH) are poised for a tough session today. Ahead of the opening bell, the drugmaker's share price ... Cramer would be careful about Aurinia Pharmaceuticals Ord Shs (NASDAQ:AUPH). Sorrento Therapeutics Inc (NASDAQ:SRNE) is overvalued, said Cramer. He is a seller.Aurinia Pharmaceuticals ( NASDAQ: AUPH) named Dr. Robert Foster as a new board member Thursday as part of an agreement with its major shareholder and investment management firm, MKT Capital Ltd ...SVB Leerink waxed optimistic on Aurinia Pharmaceuticals Inc (NASDAQ:AUPH), saying the stock could rally 250% if late-stage trial data for the company's kidney inflammation treatment shows a ...Jul 3, 2023 · Aurinia Pharmaceuticals AUPH rose almost 5.8% on Jun 30, as management announced that it is exploring strategic alternatives for the company’s future. AUPH will consider a range of options ... NEW YORK, May 18, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that...

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) shares are trading higher, adding to gains of more than 17% over the last week. The stock has been trending higher since the company announced that its ...Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (“Aurinia” or the “Company”) today announced that its Board of Directors has appointed two new directors. Dr. Karen Smith and Jeffrey A. Bailey joined the board of directors of the Company effective August 18, 2023, bringing with them decades of combined leadership experience in the ...(RTTNews) - Today's Daily Dose brings you news about the layoff in Allena Pharma; the positive phase III trial results of Aurinia Pharma's lupus drug; stock offerings of Millendo Therapeutics and ...Instagram:https://instagram. vanguard vs fidelity 529who has the best boat insuranceetfs that pay monthlybest safe stocks to buy now Instrument Name Aurinia Pharm Ord Instrument Symbol (AUPH-Q). Instrument Exchange NASDAQ · Why Aurinia Pharmaceuticals Stock Is Slumping Today · Why Aurinia ...Aurinia Pharmaceuticals' (AUPH) Buy Rating Reaffirmed at Oppenheimer. FRIDAY, MAY 7, 2021. Aurinia Pharmaceuticals (NASDAQ:AUPH) (TSE:AUP)'s stock had its "buy" rating reaffirmed by stock analysts ... best reits for incomebest sep retirement plan jurgenfr. Canadian biotech Aurinia Pharmaceuticals ( NASDAQ: AUPH) lost ~22% pre-market Thursday even after announcing better-than-expected financials for Q3 2022 as the company lowered its full ... saudi aramco stocks Home AUPH • NASDAQ Aurinia Pharmaceuticals Inc Follow Share $9.06 After Hours: $9.03 (0.33%) -0.030 Closed: Dec 1, 7:57:38 PM GMT-5 · USD · NASDAQ · Disclaimer search …And Aurinia Pharmaceuticals Inc (Symbol: AUPH) saw options trading volume of 18,237 contracts, representing approximately 1.8 million underlying shares or approximately 88.5% of AUPH's average ...MKT Capital Ltd, a shareholder with a 4.2% stake in Aurinia Pharmaceuticals Inc (NASDAQ: AUPH), has issued a letter to Aurinia shareholders with plans to withhold support for three directors at ...